Stay updated with breaking news from Globalx Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Archford Capital Strategies LLC boosted its position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free Report) by 15.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 23,076 shares of the company’s stock after purchasing an additional 3,107 shares during the […]
While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential.
Some of the top gene-editing stocks have had immense surge potential. Look at CRISPR Therapeutics, for example.
James J. Burns & Company LLC increased its position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free Report) by 8.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,939 shares of the company’s stock after […]
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Free Report) was the recipient of a large decline in short interest in September. As of September 15th, there was short interest totalling 15,500 shares, a decline of 95.9% from the August 31st total of 374,700 shares. Based on an average daily trading volume, of 189,100 […]